SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001213900-20-012347
Filing Date
2020-05-14
Accepted
2020-05-14 17:29:17
Documents
10

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea121805-s3_protaratherape.htm S-3 486471
2 FORM OF INDENTURE, BETWEEN THE COMPANY AND ONE OR MORE TRUSTEES TO BE NAMED ea121805ex4-7_protara.htm EX-4.7 347769
3 FORM OF COMMON STOCK WARRANT AGREEMENT AND WARRANT CERTIFICATE ea121805ex4-9_protara.htm EX-4.9 147969
4 FORM OF PREFERRED STOCK WARRANT AGREEMENT AND WARRANT CERTIFICATE ea121805ex4-10_protara.htm EX-4.10 135199
5 FORM OF DEBT SECURITIES WARRANT AGREEMENT AND WARRANT CERTIFICATE ea121805ex4-11_protara.htm EX-4.11 102087
6 OPINION OF COOLEY LLP ea121805ex5-1_protara.htm EX-5.1 38019
7 CONSENT OF MARCUM LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM. ea121805ex23-1_protara.htm EX-23.1 2111
8 CONSENT OF ERNST & YOUNG LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ea121805ex23-2_protara.htm EX-23.2 1843
9 GRAPHIC image_001.jpg GRAPHIC 10972
10 GRAPHIC ex5-1_001.jpg GRAPHIC 7517
  Complete submission text file 0001213900-20-012347.txt   1288358
Mailing Address 1 LITTLE WEST 12TH STREET NEW YORK NY 10014
Business Address 1 LITTLE WEST 12TH STREET NEW YORK NY 10014 646-844-0337
Protara Therapeutics, Inc. (Filer) CIK: 0001359931 (see all company filings)

IRS No.: 204580525 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-238273 | Film No.: 20879206
SIC: 2836 Biological Products, (No Diagnostic Substances)